Bulkamid is a homogenous hydrophilic hydrogel used in the treatment of female stress urinary incontinence.
Bulkamid was granted CE approval in 2003 for use in the treatment of female urinary incontinence. More than 50,000 people have been treated to date, in over 25 countries, with a procedure that is performed under endoscopic control using the Bulkamid Urethral Bulking System. The efficacy and safety of Bulkamid have been documented in a number of international clinical studies involving more than 3,000 patients.
Aquamid is a non-absorbable hydrogel that is used to rejuvenate and contour the face
Aquamid does this by restoring lost volume or by adding extra volume where desired. As it does not degrade over time, the aesthetic results remain for years. The efficacy and safety of Aquamid have been documented in a number of international clinical studies involving more than 5,000 patients. Over 500,000 people have been treated with Aquamid since its launch.
Aquamid Reconstruction is a non-absorbable hydrogel for soft tissue augmentation.
Aquamid Reconstruction is a non-absorbable high viscoelastic hydrogel for soft tissue augmentation where the areas to be treated require more volume or higher elasticity to provide additional volume. Aquamid Reconstruction has been successfully used in patients with facial lipoatrophy, amongst others, and its safety and efficacy data show excellent results over a period of more than 10 years.
PRODUCTS WE DISTRIBUTE
Regurin XL is indicated to help control the symptoms of an overactive bladder.
Regurin XL (prolonged release Trospium chloride) is one of the anticholinergics recommended by NICE for the treatment of urinary incontinence in women.
The product is licensed from the Mylan Group of companies. Contura distributes Regurin XL in the UK.
Cystistat is a sterile sodium hyaluronate solution for temporary replacement of the glycosaminoglycan layer in the bladder helping to protect it against natural irritants, treating interstitial Cystitis.
Cystistat is an intravesical therapy which has treated over 800,000 patients worldwide. The product is licensed from the Mylan Group of companies. Contura distributes Cystistat in Germany and France.